Publication:
Double-dose ivermectin vs albendazole for the treatment of gnathostomiasis

dc.contributor.authorPonganant Nontasuten_US
dc.contributor.authorBo A. Claessonen_US
dc.contributor.authorParon Dekumyoyen_US
dc.contributor.authorWallop Pakdeeen_US
dc.contributor.authorSukvannee Chullawichiten_US
dc.contributor.otherMahidol Universityen_US
dc.contributor.otherSahlgrenska Universitetssjukhuseten_US
dc.contributor.otherThe Hospital for Tropical Diseases, Bangkoken_US
dc.date.accessioned2018-06-21T08:28:10Z
dc.date.available2018-06-21T08:28:10Z
dc.date.issued2005-05-01en_US
dc.description.abstractA comparative study was performed for the treatment of gnathostomiasis patients with ivermectin 0.2 mg/kg for 2 days in 15 patients vs albendazole 400 mg twice daily for 21 days in 14 patients. The ivermectin and albendazole gave cure rates of 100% and 78.5%, respectively, however the difference was not statistically significant between the two drugs (Fisher's exact, p=0.0996). One year after treatment, the patients who had no migratory swellings and a drop in ELISA titers or a negative immunoblot test were considered to be cured. The side effect of ivermectin for two days was dizziness. The side effects of albendazole were nausea, dizziness, and an increased alkaline phosphatase.en_US
dc.identifier.citationSoutheast Asian Journal of Tropical Medicine and Public Health. Vol.36, No.3 (2005), 650-652en_US
dc.identifier.issn01251562en_US
dc.identifier.other2-s2.0-24944479126en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/16992
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=24944479126&origin=inwarden_US
dc.subjectMedicineen_US
dc.titleDouble-dose ivermectin vs albendazole for the treatment of gnathostomiasisen_US
dc.typeArticleen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=24944479126&origin=inwarden_US

Files

Collections